Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Side Effects A Single Blinded Randomised Controlled Study

NCT03038321 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT03038321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Side Effects A Single Blinded Randomised Controlled Study
Lead sponsor
Mansoura University
Phase
Phase 4
Overall status
Unknown status
Start date
February 1, 2017
Completion date
December 31, 2019
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacillus calmette-guerin (bcg) cystitis, intra-vesical instillation, non-muscle-invasive bladder cancer (nmibc)